Investing
Cathie Wood's ARK Invest Sells Over 840,000 Shares of Seres Therapeutics
Published:
One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.
Here are all the ARK Invest sales on Monday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 981,100 |
| ARKF | 9923HK | YEAHKA | 297,200 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 10,518 |
| ARKG | CLLS | CELLECTIS | 7,300 |
| ARKG | RHHBY | ROCHE | 78,900 |
| ARKK | MCRB | SERES THERAPEUTICS | 846,468 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 71,749 |
| ARKQ | ISRG | INTUITIVE SURGICAL | 1,700 |
| ARKQ | NXPI | NXP SEMICONDUCTORS | 13,000 |
| ARKQ | BABA | ALIBABA | 15,089 |
| ARKQ | GOOG | ALPHABET | 4,808 |
| ARKW | MELI | MERCADOLIBRE | 4,500 |
| ARKW | SE | SEA | 34,049 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
24/7 Wall St.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
